RNA INTERFERENCE (RNAI): AN EFFECTIVE WAY TO DEVELOP RATIONAL COMBINATION THERAPIES WITH HYPOMETHYLATING AGENTS IN ACUTE LEUKAEMIAS AND MYELODYSPLASTIC SYNDROME

Therapeutic progress in aggressive myeloid malignancies such as acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and advanced myeloproliferative neoplasm (MPNs) has been slow. This is partially due to the heterogeneity of the diseases and the lack of molecular understanding, which delay...

Full description

Bibliographic Details
Main Author: Raoul Tibes
Format: Article
Language:English
Published: European Medical Journal 2013-08-01
Series:European Medical Journal Hematology
Subjects:
Online Access:https://emj.emg-health.com/wp-content/uploads/sites/2/2013/08/EMJ-Hematology.-Raoul-Tibes..pdf